SKIBSTED RUSSELL 4
4 · BIOTIME INC · Filed Oct 9, 2018
Insider Transaction Report
Form 4
BIOTIME INCBTX
SKIBSTED RUSSELL
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares, no par value
2018-10-04+11,250→ 13,250 total - Tax Payment
Common Shares, no par value
2018-10-04$2.22/sh−3,891$8,638→ 9,359 total - Exercise/Conversion
Restricted Stock Units
2018-10-04−11,250→ 33,750 totalExercise: $0.00→ Common Shares (11,250 underlying)
Footnotes (4)
- [F1]Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units ("RSUs") granted to the Reporting Person on May 24, 2018.
- [F2]Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options.
- [F3]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,250 RSUs, the grant of which was previously reported on a Form 8-K.
- [F4]25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, then the remaining 75% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.